Phorbol 12-myristate 13-acetate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePhorbol 12-myristate 13-acetate
Drug Alias NamePhorbol myristate acetateTetradecanoylphorbol acetatePD-616RP 323TPA +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C stimulants
TargetsProtein kinase C
Therapy Area/IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesMyelodysplastic-Myeloproliferative Diseases +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiosuccess Biotech Co LtdNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Medicine And Dentistry Of New JerseyBiosuccess Biotech Co LtdNational Cancer Institute +[4] 
Active IndicationsN/A
Inactive IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesMyelodysplastic-Myeloproliferative Diseases +[9] 

Other Information

ATC CodeN/A
Related LinksWikipedia